Search
Search Results
##search.searchResults.foundPlural##
-
THE SPECTRUM OF GENETIC DEFECTS IN CHRONIC LYMPHOCYTIC LEUKEMIA
2373PDF: 941HTML: 2022Fig 1 Rossi: 247 -
BLINATUMOMAB IN THE THERAPY OF ACUTE B-LYMPHOID LEUKEMIA BLINATUMOMAB and ALL
1778PDF: 1162HTML: 180 -
Coronavirus disease 2019 (COVID-19) severity in patients with thalassemias: A Nationwide Iranian Experience Coronavirus in patients with thalassemias
1558PDF: 560HTML: 208 -
THE ROLE OF AUTOLOGOUS AND ALLOGENEIC STEM CELL TRANSPLANTATION IN FOLLICULAR LYMPHOMA IN THE NEW DRUGS ERA.
4210PDF: 1230HTML: 2118Fig.1: 246Fig. 2: 138Table 1: 250Table2: 272Table 3: 246 -
-
Magnusiomyces capitatus Breakthrough Infection in Allogeneic Hematopoietic Cell Transplant Recipients Receiving Echinocandin Prophylaxis: Clinical Features, Management, and Review of the Literature
105PDF: 167Suppl. Files: 22Html: 107Html Suppl. Files: 81 -
THE EVOLVING ROLE OF RADIOTHERAPY IN EARLY STAGE HODGKIN’S LYMPHOMA
2350PDF: 1019HTML: 6866Figure 1: 216 -
MANAGEMENT OF PORTAL VEIN THROMBOSIS IN CIRRHOTIC PATIENTS
868PDF: 584HTML: 4041 -
CANDIDA ASSOCIATED BLOODSTREAM INFECTIONS IN PEDIATRIC HEMATOLOGY PATIENTS: SINGLE CENTER EXPERIENCE
4528PDF: 991HTML: 1368Table1: 251 -
Peripheral Red Blood Cell Split Chimerism as a Consequence of Intramedullary Selective Apoptosis of Recipient Red Blood Cells in a Case of Sickle Cell Disease
1764PDF: 1064HTML: 1896Untitled: 246Untitled: 223 -
Guest Editor: G. Castaman AGING WITH HEMOPHILIA: THE CHALLENGE OF APPROPRIATE DRUG PRESCRIPTION Hemophilia and aging
3056PDF: 1522HTML: 331 -
THROMBOCYTOPENIA IN PATIENTS WITH CHRONIC HEPATITIS C VIRUS INFECTION
4369PDF: 2086HTML: 1970 -
IS HEMOGLOBIN E GENE WIDELY SPREAD IN THE STATE OF MADHYA PRADESH IN CENTRAL INDIA? EVIDENCE FROM FIVE TYPICAL FAMILIES
2681PDF: 942HTML: 8000Untitled: 232 -
SICKLE CELL ANAEMIA AND MALARIA
11917PDF: 7353HTML: 24086Figures Malaria and SCK: 275 -
NUTRITIONALLY VARIANT STREPTOCOCCI BACTEREMIA IN CANCER PATIENTS: A RETROSPECTIVE STUDY, 1999-2014
2273PDF: 1076HTML: 4108Cover Letter: 265Figure 1: 278Figure 2: 270Table 1: 254 -
SIMPLE PERIPHERAL BLOOD SMEAR FINDINGS OF COVID-19 PATIENTS PROVIDE INFORMATION ABOUT THE SEVERITY OF THE DISEASE AND THE DURATION OF HOSPITAL STAY. Peripheral blood smear and COVID-19 severity.
3707PDF: 1285HTML: 522 -
CLINICAL AND LABORATORY FEATURES OF SICKLE CELL DISEASE S/D PUNJAB: IMPACT OF HBF AND HYDROXYUREA SCD S/D Punjab
1447PDF: 1222HTML: 162 -
IMPORTANCE OF HYPERBILURUBINEMIA IN DIFFERENTIATION OF PRIMARY AND SECONDARY HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS IN PEDIATRIC CASES
1881PDF: 999HTML: 1202Untitled: 205Untitled: 227Untitled: 213Untitled: 201 -
PATHOBIOLOGY OF HODGKIN LYMPHOMA
3415PDF: 1565HTML: 5973Fig1-Ag-Pil: 285Ag-Pil Fig.2: 285 -
TP53-MUTATED MYELODYSPLASIA AND ACUTE MYELOID LEUKEMIA TP53 in MDS and AML
2410PDF: 1892HTML: 1011 -
DIAGNOSIS OF MALARIA INFECTION WITH OR WITHOUT DISEASE
3759PDF: 1192HTML: 23383 -
-
SIMILARITIES OF ELDERLY AND THERAPY-RELATED AML
3853PDF: 972HTML: 6888 -
-
MODERN IMMUNOTHERAPY OF ADULT B-LINEAGE ACUTE LYMPHOBLASTIC LEUKEMIA WITH MONOCLONAL ANTIBODIES AND CHIMERIC ANTIGEN RECEPTOR MODIFIED T CELLS
2453PDF: 1391HTML: 17221Bassan Fig.1: 183Bassan Fig.2: 287Bassan Fig.4: 173Fig.3: 269 -
A Rare Case of Rosai-Dorfman Disease in an Adult Male Associated with Auto-immune Hemolytic Anemia.
1465PDF: 987HTML: 1680Figure 1: 224 -
CMV MANAGEMENT WITH SPECIFIC IMMUNOGLOBULINS: A MULTICENTRIC RETROSPECTIVE ANALYSIS ON 92 ALLOTRANSPLANTED PATIENTS. Anti-CMV immunoglobulins for CMV treatment
2750PDF: 1253HTML: 287 -
HISTORY OF ACUTE PROMYELOCYTIC LEUKEMIA: A TALE OF ENDLESS REVOLUTION
3326PDF: 1182HTML: 1987 -
MUTATIONAL PROFILES OF F8 AND F9 IN A COHORT OF HAEMOPHILIA A AND HAEMOPHILIA B PATIENTS IN THE MULTI-ETHNIC MALAYSIAN POPULATION
2185PDF: 1131HTML: 978Figure 1: 214Figure 2: 236 -
ZYGOMYCOSIS IN IMMUNOCOMPROMISED NON-HAEMATOLOGICAL PATIENTS
3026PDF: 1043HTML: 7519 -
CAUSES OF ADULT SPLANCHNIC VEIN THROMBOSIS IN THE MEDITERRANEAN AREA
2755PDF: 1008HTML: 3734 -
“IDENTIFYING HIGH-RISK CHRONIC LYMPHOCYTIC LEUKEMIA: A PATHOGENESIS-ORIENTED APPRAISAL OF PROGNOSTIC AND PREDICTIVE FACTORS IN PATIENTS TREATED WITH CHEMOTHERAPY WITH OR WITHOUT IMMUNOTHERAPY.”
4100PDF: 1128HTML: 3910Untitled: 203Cneo. Fig.1: 145Untitled: 136Untitled: 167Untitled: 172 -
CLINICAL ASPECTS AND THERAPY OF SPORADIC BURKITT LYMPHOMA
1430PDF: 642HTML: 4193







